Nebius Stock: Already Around 240% This Year—Is It Worth Buying?
Nebius Group has rocketed more than 240% this year. Before you jump in, learn how to weigh momentum against fundament...
This quick comparison outlines safety essentials between stablecoins and other crypto assets, with practical tips for cautious investors.
21,083 articlesNebius Group has rocketed more than 240% this year. Before you jump in, learn how to weigh momentum against fundament...
A new class action filed in California claims Kalshi misled traders in a Khamenei leadership prediction market, resul...
Saudi’s sovereign wealth fund outlines a bold pivot to make the kingdom a global investment center, with an 80/20 dom...
Defense orders for long-range artillery systems reshaping modern warfare are driving a fresh wave of investor interes...
As AI use grows across major tech firms, worker morale and collaboration are under strain. A close look at Anthropic’...
As 2026 unfolds, lawmakers and the Social Security Administration weigh reforms that could reduce benefits for 66-yea...
As markets adjust to higher-for-longer rates, three Dividend Kings stand out as defensive anchors for a $1.5 million ...
California prices could soon surge past seven dollars per gallon as crude costs climb and refining limits bite, with ...
When a high-flying IPO lands, the real work begins. Here are five practical milestones that space tech investors shou...
A short clip of a man in Brampton clearing snow with a lawnmower exploded into a national conversation about who belo...
On a midweek Tuesday when tech stocks sagged, Salesforce bucked the trend. A fresh bullish note from a respected anal...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...